Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)-Reference-Cited by-同舟云学术

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)

Published:2009-10 Issue:2 Volume:206 Page:535-539
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Oikawa Shinichi,Yokoyama Mitsuhiro,Origasa Hideki,Matsuzaki Masunori,Matsuzawa Yuji,Saito Yasushi,Ishikawa Yuichi,Sasaki Jun,Hishida Hitoshi,Itakura Hiroshige,Kita Toru,Kitabatake Akira,Nakaya Noriaki,Sakata Toshiie,Shimada Kazuyuki,Shirato Kunio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23);Turner;British Medical Journal,1998

2. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S);Pyorala;Diabetes Care,1997

3. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial;Goldberg;The Care Investigators, Circulation,1998

4. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial;Keech;Diabetes Care,2003

5. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin;Downs;The American Journal of Cardiology,2001

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triglyceride/High Density Lipoprotein Cholesterol Index and Future Cardiovascular Events in Diabetic Patients without Known Cardiovascular Disease;2024-09-01

2. Functional Lipids and Cardiovascular Disease Reduction: A Concise Review;Nutrients;2024-07-28

3. JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease;Circulation Journal;2024-04-25

4. Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes;Antioxidants;2023-12-28

5. Do patients benefit from omega-3 fatty acids?;Cardiovascular Research;2023-12